116 related articles for article (PubMed ID: 17460891)
1. [Expression and characterization of fusion protein tTF/SA as a universal effector for targeting blood coagulation].
Wang Z; Yan JH; Wang JP; Xie LY; Wu N
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):218-22. PubMed ID: 17460891
[TBL] [Abstract][Full Text] [Related]
2. [Gene expression and activities analysis of a new fusion protein (RGD) 3/tTF].
Yan JH; Yang GW; Wang JP; Wu N; Zhuang GH
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):409-12. PubMed ID: 17577984
[TBL] [Abstract][Full Text] [Related]
3. Tissue-factor fusion proteins induce occlusion of tumor vessels.
Schwöppe C; Kessler T; Persigehl T; Liersch R; Hintelmann H; Dreischalück J; Ring J; Bremer C; Heindel W; Mesters RM; Berdel WE
Thromb Res; 2010 Apr; 125 Suppl 2():S143-50. PubMed ID: 20433995
[TBL] [Abstract][Full Text] [Related]
4. [Expression, purification and bioactivity evaluation of streptavidin-tagged human interleukin-21 fusion protein].
Fa PP; Zhang Z; Li JL; Hu ZM; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1240-3, 1249. PubMed ID: 20584646
[TBL] [Abstract][Full Text] [Related]
5. Purification of CD47-streptavidin fusion protein from bacterial lysate using biotin-agarose affinity chromatography.
Salehi N; Peng CA
Biotechnol Prog; 2016 Jul; 32(4):949-58. PubMed ID: 27110670
[TBL] [Abstract][Full Text] [Related]
6. [Arginine-glycine-aspartic polypeptide mediated truncated tissue factor therapy for colorectal carcinoma].
Huang ZJ; Luo Q; Yan JH; Wang SY
Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(8):619-24. PubMed ID: 20646482
[TBL] [Abstract][Full Text] [Related]
7. Generation of fusion proteins for selective occlusion of tumor vessels.
Kessler T; Schwöppe C; Liersch R; Schliemann C; Hintelmann H; Bieker R; Berdel WE; Mesters RM
Curr Drug Discov Technol; 2008 Mar; 5(1):1-8. PubMed ID: 18537561
[TBL] [Abstract][Full Text] [Related]
8. A recombined fusion protein SP5.2/tTF induce thrombosis in tumor blood vessel.
Lv S; Ye M; Wang X; Li Z; Chen X; Dou X; Dai Y; Zeng F; Luo L; Wang C; Li K; Luo X; Yan J; Li X
Neoplasma; 2015; 62(4):531-40. PubMed ID: 25997964
[TBL] [Abstract][Full Text] [Related]
9. [Expression, purification and refolding of streptavidin-tagged human tumor necrosis factor-alpha fusion protein].
Xu CX; Hu ZM; Li JL; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):412-5. PubMed ID: 19304513
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and application of a novel HCV diagnostic antigen fused to streptavidin].
Zhang TY; Lu J; Zhao M; Zhao GX; Deng Y; Bi SL; Gao JM; Tan WJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):230-2. PubMed ID: 21977601
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and bioactivity evaluation of streptavidin-tagged human interleukin-15 fusion protein].
Su H; Chen YL; Chen SY; Wen B; Yu HS; Hu ZM; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):397-401. PubMed ID: 19304509
[TBL] [Abstract][Full Text] [Related]
12. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
[TBL] [Abstract][Full Text] [Related]
13. [Humanized monoclonal antibody TNT-3-mediated truncated tissue factor for the treatment of H22 hepatoma-bearing mice].
Huang ZJ; Wang R; Liu ZZ; Wang SY; Yan JH; Luo Q
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):249-53. PubMed ID: 22781034
[TBL] [Abstract][Full Text] [Related]
14. Production of extracellular domain of human tissue factor using maltose-binding protein fusion system.
Guan M; Su B; Ye C; Lu Y
Protein Expr Purif; 2002 Nov; 26(2):229-34. PubMed ID: 12406676
[TBL] [Abstract][Full Text] [Related]
15. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
16. Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein.
Wang WW; Das D; McQuarrie SA; Suresh MR
Eur J Pharm Biopharm; 2007 Mar; 65(3):398-405. PubMed ID: 17257818
[TBL] [Abstract][Full Text] [Related]
17. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW
Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification.
Voss S; Skerra A
Protein Eng; 1997 Aug; 10(8):975-82. PubMed ID: 9415448
[TBL] [Abstract][Full Text] [Related]
19. [Construction of the expression vector pET32a/His MBL-CLR and its expression in E.coli].
Cai XM; Zuo DM; Zhao N; Zhang LY; Chen ZL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):25-7, 31. PubMed ID: 17210100
[TBL] [Abstract][Full Text] [Related]
20. Autodisplay of streptavidin.
Park M; Jose J; Thömmes S; Kim JI; Kang MJ; Pyun JC
Enzyme Microb Technol; 2011 Apr; 48(4-5):307-11. PubMed ID: 22112942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
